Abstract
The study has been designed to investigate the effect of demethylasterroquinone B1 (DAQ B1), an activator of Akt, in diabetes mellitus (DM) and hyperhomocyteinemia (HHcy)-induced vascular endothelial dysfunction. Streptozotocin (55 mg kg−1, i.v.) and methionine (1.7% w/w, p.o., 4 weeks) were administered to rats to produce DM (serum glucose >140 mg dl−1) and HHcy (serum homocysteine >10 µM), respectively. Vascular endothelial dysfunction was assessed using isolated aortic ring preparation, electron microscopy of thoracic aorta and serum concentration of nitrite/nitrate. The expression of messenger RNA for p22phox and eNOS was assessed by reverse transcription-polymerase chain reaction. Serum thiobarbituric acid reactive substances (TBARS) and aortic superoxide anion were estimated to assess oxidative stress. DAQ B1 (5 mg kg−1, p.o.) or atorvastatin (30 mg kg−1, p.o.) in diabetic and hyperhomocysteinemic rats significantly reduced serum glucose and homocysteine concentration. DAQ B1 or atorvastatin markedly improved acetylcholine-induced endothelium-dependent relaxation, vascular endothelial lining, serum nitrite/nitrate concentration and serum TBARS in diabetic and hyperhomocysteinemic rats. However, this ameliorative effect of DAQ B1 has been prevented by L-NAME (25 mg kg−1, i.p.), an inhibitor of eNOS. Therefore, it may be concluded that DAQ B1-induced activation of Akt may activate eNOS and consequently reduce oxidative stress to improve vascular endothelial dysfunction.
Similar content being viewed by others
References
De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963–974
Lentz SR, Rodionov RN, Dayal S (2003) Hyperhomocysteinemia, endothelial dysfunction and cardiovascular risk: the potential role of ADMA. Atheroscler Suppl 4:61–65
Luscher TF, Vanhoutte PM (1987) Endothelium dependent vascular response in normotensive and hypertensive dahl rats. Hypertension 9:157–163
Bonetti PO, Lerman L, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168–175
Pieper GM, Langenstroer P, Siebeneich W (1997) Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 37:145–156
Ungwari Z, Paeher P, Rischak K, Szollar L, Koller A (1999) Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocystenemia. Arterioscler Thromb Vasc Biol 19:1899–1904
Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollar L, Koller A (2000) Simultaneously increased TXA2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 20:1203–1208
Li H, Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244–262
Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992
Dimmeler S, Fleming B, Fisslthaler B, Herman C, Busse B, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropolous A, Sessa WC (1999) Regulation of endothelium derived nitric oxide production by the protein kinase Akt. Nature 400:792
Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M (2005) Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice. J Hypertens 23:1383–1389
Hanada M, Feng J, Hemmings BA (2004) Structure, regulation and function of PKB/Akt – a major therapeutic target. Biochem Biophys Acta 1697:3–16
Iaccarino G, Ciccarelli M, Sorriento D, Cipoletta E, Cerullo V, Iovino GL, Paudice A, Elia A, Santulli G, Campanile A, Arcuccie O, Pastore L, Salvatore F, Condorelli G, Trimareo B. (2004) Akt participates in endothelial dysfunction in hypertension. Circulation 109:2587–2593
Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I, Vilella D, Diez MT, Peelaez F, Rubey C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG, Moller DE (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284:974–977
Westerlund J, Wolf BA, Bergsten P (2002) Glucose dependent promotion of insulin release from mouse pancreatic islet by the insulin-mimetic compound L-783,281. Diabetes 51:S50–S52
Webster NG, Park K, Pirrung MC (2003) Signaling effect of demethylasterroquinone b1, a selective insulin receptor modulator. ChemBioChem 4:379–385
Dimitrova KR, DeGroot KW, Pacquing AM, Suyderhoud JP, Pirovic EA, Munro TJ, Wieneke JA, Myers AK, Kim YD (2002) Estradiol prevents homocysteine-induced endothelial injury in male rats. Cardiovasc Res 53:589–596
Mitra S, Singh M (1998) Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Mol Cell Biochem 183:63–67
Ignarro LJ, Bryns RE, Buga GM, Wood KS, Chaudhari G (1988) Pharmacological evidence that endothelium-derived relaxing factor is NO: use of pyrogallol and superoxide dismutase to study endothelium dependent and NO-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244:181–188
Schiller NK, Timothy AM, Chen IL, Rice RC, Akers DL, Kadowitz PJ, McNamaran DB (1999) Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. Am J Physiol 277:240–248
Chomezynskl P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Anal Biochem 162:156–159
Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306:79–82
Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quihin MT, Brecher P (1998) Cohen RASuperoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82:810–818
Ma FA, Liu LY, Xiong XM (2003) Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacol Sin 24:1027–1032
Kohn AD, Summer SA, Birnbaum MJ, Roth RA (1996) Expression of constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372–31378
Calera MR, Martinez C, Liu H, Jack AKE, Birnbaum MJ, Pilch PF (1998) Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem 273:7201–7204
Burgering BMT, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599–602
Begum N, Sandu OA, Ito M, Lohman SM, Smolenski A (2001) Active Rho kinase associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 22:6214–6222
Waly M, Olteanu H, Banerjee R, Choi S-W, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky V-A, Deth RC (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopemental toxins and thimerosal. Mol Psychiatry 9:358–370
Fonesca V, Keebler M, Dicker-Brown A, DeSouza C, Poirier LA, Murthy SN, McNamara DB (2002) The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in zucker rats. Metabolism 61:783–786
Zdychova J, Komers R (2005) Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 54:1–16
Zhang HS, Cao EH, Qin JF (2005) Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology 74:57–64
Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395–403
Potente M, Urbich C, Sasaki KI, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115:2382–2392
Toba H, Gomyo E, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Asayama J, Kobara M, Nakata T (2006) Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/akt pathway in rat aorta. Clin Exp Pharmacol Physiol 33:440–447
Kung CF, Moreau P, Takase H, Luscher TF (1994) L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Hypertension 26:744–750
Hayden MR, Tyagi SC (2004) Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleotropic effects of folate supplementation. Nutr J 3:4–27
Zalba G, Beaumont FJ, San Jose G, Fortuño A, Fortuño MA, Etayo JC, Díez J (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055–1061
van Heerebeek L, Meischl C, Stooker W, Meijer CJLM, Niessen HWM, Ross D (2002) NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 55:561–568
Kobayashi N, Mita S, Yoshida K (2003) Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 via NF-κB induced by oxidative stress. Hypertension 42:1004–1013
Wagner AH, Schroeter MR, Hecker M (2001) 17ß-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15:2121–2130
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, D.I., Singh, M. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Mol Cell Biochem 295, 65–74 (2007). https://doi.org/10.1007/s11010-006-9273-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-9273-9